Cargando…

Updating the VIVOPTIM Program for the Assessment of Cardiovascular Risk

Detalles Bibliográficos
Autores principales:	Blacher, Jacques, Femery, Virginie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558032/ https://www.ncbi.nlm.nih.gov/pubmed/34737571 http://dx.doi.org/10.2147/VHRM.S333542

Ejemplares similares

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
por: Pawar, Ajinkya, et al.
Publicado: (2021)

Assessing Cardiovascular Risk in Patients with Diabetes: An Update
por: Damaskos, Christos, et al.
Publicado: (2020)

Atherogenic Index of Plasma for the Assessment of Cardiovascular Risk Factors
por: Joob, Beuy, et al.
Publicado: (2017)

An Updated Version of the Treatment Effectiveness Assessment (TEA) [Letter]
por: Ling, Walter, et al.
Publicado: (2020)

Traffic noise and cardiovascular disease mortality: A risk assessment
por: Kawada, Tomoyuki
Publicado: (2021)

Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial
por: Galan, Pilar, et al.
Publicado: (2010)

The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)

Cardiovascular risk assessment for patients with serious mental illnesses: An internal review
por: Alshawwaf, Mahmoud, et al.
Publicado: (2021)

Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment
por: Zolezzi, Monica, et al.
Publicado: (2020)

Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?
por: Gabet, Amélie, et al.
Publicado: (2022)

Towards an update in the neurophysiological assessment of functional tremors
por: Bocci, Tommaso, et al.
Publicado: (2019)

Determinants of Major Cardiovascular Risk Factors Among Participants of the South Carolina WISEWOMAN Program, 2009–2012
por: Nahhas, Georges Joseph, et al.
Publicado: (2014)

Update on the Risks of Electronic Cigarettes—Vaping
por: Reasoner, Jeremiah J., et al.
Publicado: (2020)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
por: Vivekanandan, S
Publicado: (2012)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy
por: Roy, Parthasarathi
Publicado: (2013)

Update on Cardiovascular Risk and Obesity in Psoriatic Arthritis
por: Ramírez, Julio, et al.
Publicado: (2021)

Sex and Education Background of Cardiovascular Disease Trainees and Program Directors in the United States
por: Thakker, Ravi, et al.
Publicado: (2022)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy: Comment
por: Arunachalam, Cynthia
Publicado: (2012)

Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy-Comment
por: Vivekanandan, Sachidanandam
Publicado: (2013)

Atherosclerostic cardiovascular disease risk score: Are Indians underestimating the risk of cardiovascular disease?
por: Kumar, Ashish, et al.
Publicado: (2019)

Pakistan as a major obstacle in global end to poliomyelitis program: background and 2016 update
por: Khan, Abdul Waheed, et al.
Publicado: (2016)

Three updates
por: Sahni, V.
Publicado: (2020)

PPE update
por: Sahni, V.
Publicado: (2020)

Cardiovascular disease risk stratification in type 2 diabetes
por: Esdaile, Harriet, et al.
Publicado: (2022)

Imagem Cardiovascular em Pacientes com COVID-19
por: Grossman, Gabriel Blacher, et al.
Publicado: (2020)

Cardiovascular risk assessment in lupus nephritis and ANCA-associated vasculitis in real-world nephrology practice
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Assessing cardiovascular risk in regional areas: the Healthy Hearts – Beyond City Limits program
por: Carrington, Melinda J, et al.
Publicado: (2012)

Baseline Plasma Fatty Acids Profile and Incident Cardiovascular Events in the SU.FOL.OM3 Trial: The Evidence Revisited
por: Fezeu, Léopold K., et al.
Publicado: (2014)

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
por: Dougados, Maxime, et al.
Publicado: (2023)

Red and processed meat and risk of colorectal cancer: an update
por: Benarba, Bachir
Publicado: (2018)

An Update on Cardiovascular Risk Factors After Kawasaki Disease
por: Zeng, Yuan-Yuan, et al.
Publicado: (2021)

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
por: Montecucco, Fabrizio, et al.
Publicado: (2012)

Gestational Diabetes Mellitus and Future Cardiovascular Risk: An Update
por: Burlina, S., et al.
Publicado: (2016)

Cardiovascular Disease Risk in Obstructive Sleep apnea: An Update
por: Yacoub, Mena, et al.
Publicado: (2018)

Vaping Cardiovascular Health Risks: an Updated Umbrella Review
por: Peruzzi, Mariangela, et al.
Publicado: (2020)

The Role of Fructose as a Cardiovascular Risk Factor: An Update
por: Busnatu, Stefan-Sebastian, et al.
Publicado: (2022)

Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence
por: Carter, Sharayah, et al.
Publicado: (2023)

Assessment of cardiovascular risk in hypertensive patients: a comparison of commonly used risk scoring programs
por: Ulusoy, Şükrü
Publicado: (2013)

Basic training in cardiovascular anesthesia: wouldn’t it be the time for a unified program in Brazil?
por: Nigro Neto, Caetano, et al.
Publicado: (2021)

Black tea, green tea and risk of breast cancer: an update
por: Wu, Yili, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bn30s4tuu79lt5gi31jj0eag50